ישראל - עברית - Ministry of Health

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - famotidine - טבליה - famotidine 40 mg - famotidine

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 30 mg - duloxetine

ישראל - עברית - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole

ישראל - עברית - Ministry of Health

teva israel ltd - famotidine - טבליה - famotidine 40 mg - famotidine

ישראל - עברית - Ministry of Health

inovamed ltd - ramipril - טבליה - ramipril 10 mg - ramipril

ישראל - עברית - Ministry of Health

inovamed ltd - ramipril - טבליה - ramipril 2.5 mg - ramipril

ישראל - עברית - Ministry of Health

inovamed ltd - ramipril - טבליה - ramipril 5 mg - ramipril

ישראל - עברית - Ministry of Health

rafa laboratories ltd - ramipril - קפסולות - ramipril 10 mg - ramipril - ramipril - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients suffering from impaired renal function.